# Novarcel Group

Novarcel Group is a Single Family Office based in Hong Kong, Hong Kong.

## Overview

- **Organization type:** Single Family Office
- **Headquarters:** Hong Kong, Hong Kong
- **Region:** Asia
- **Address:** Hong Kong, Hong Kong
- **Assets under management:** 43 (Altss estimate)
- **Website:** www.novarcel.com

## Regulatory record

- **Reports private funds:** No

## About

Lili Huang established Novarcel Group as a single-family office based in Hong Kong. The firm maintains a diversified book spanning public equities, private equity, and private credit. Novarcel Group targets growth equity and venture stages from Series A through Series D. It has recorded co-investments in Sirnaomics Ltd. with Wang Xuning, Daofeng He, Angela Cui He, Smooth River Limited, and Thinkreal Holdings Limited. Geographic reach covers Asia and North America. Asset classes include fund-of-funds commitments alongside direct biotechnology holdings. The firm lists no additional offices or disclosed headcount. No dated operational events from the past 24 months appear in available records. Novarcel Group operates through a concentrated ownership structure with Lili Huang as ultimate beneficial owner, limiting external mandates and preserving direct control over allocation decisions.

## Sectors

- Healthcare Services
- Digital Health

## People

- Lili Huang — Founder

## Questions

### Who runs investment decisions at Novarcel Group?

Lili Huang serves as founder and ultimate beneficial owner. No additional investment committee members are named in available records.

### Does Novarcel Group participate in fund commitments or only direct deals?

The firm uses both fund-of-funds vehicles and direct co-investments. Confirmed activity includes Series C2 and Series E rounds in Sirnaomics Ltd.

### Which sectors does Novarcel Group target?

Documented focus areas are Healthcare Services and Digital Health, with emphasis on biotechnology.

### Where does Novarcel Group invest geographically?

Allocations span Asia and North America.

### What investment stages does Novarcel Group typically target?

Activity centers on Growth, Series A, Series B, Series C, and Series D rounds.

## Related profiles

- [Michano](https://altss.com/profile/michano)
- [Barrett Capital Management](https://altss.com/profile/barrett-capital-management-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/novarcel-group

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology